Hospital doctors' perceived barriers to pharmacist prescribing

International Journal of Pharmacy Practice

Volumn 7, Issue 4, 1999, Pages 230-237

  Child, Damian ^a,b   Cantrill, Judith A ^c  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b Clinical Services   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; HEALTH CARE POLICY; HOSPITAL PHYSICIAN; HUMAN; NORMAL HUMAN; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESPONSIBILITY; UNITED KINGDOM;

EID: 0033377113     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1999.tb00974.x     Document Type: Article

References (44)

1. British National Formulary. Number 37. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, March 1999.
2. Legge A. Nurse prescribing is a success. BMJ 1997;314:464.
3. Medicines, ethics and practice: a guide for pharmacists. Number 22. London: Royal Pharmaceutical Society of Great Britain, July 1999:6.
4. A report on the supply and administration of medicines under group protocols. Health Services Circular HSC 1998/051. Leeds: NHS Executive, Department of Health, 1998.
5. Review of prescribing, supply and administration of medicines. Final report. Department of Health, March 1999.
6. Pharmacist prescribing -all ahead slow. Pharm J 1999;262:345.
7. Doctors resist pharmacist prescribing. Pharm J Ibid 1999;262:530.
8. Identification of the pharmacist's role. Pharm J Ibid 1976;216:271-2.
9. Ryan M, Bond C. Dispensing physicians and prescribing pharmacists. Pharmacoeconomics 1994;5(1):8-17.
10. Pharmacist prescribing. The Supplement. Number 819. National Pharmaceutical Association, September 1997.
11. Society calls for broad prescribing role for pharmacists. Pharm J 1997;259:399-403.
12. Hamley JG. Pharmacists as prescribers. Hospital Pharmacist 1997;4(1):2.
13. Furmaga EM. Pharmacist management of a hyperlipidaemia clinic. Am J Hosp Pharm 1993;50:91-5.
14. Morreale AP. Pharmacist-managed Helicobacter pylori clinic. Am J Health-Syst Pharm 1995;52:183-5.
15. Dong BJ, Echaves SA, Brody RV, Shapiro DW. Pharmacist provision of preventative health care services in a hypertension clinic. Am J Health-Syst Pharm Ibid 1997;54:564-6.
16. Horne AL, Dapolite LA. Protocol for pharmacist management of antineoplastic drug-induced adverse effects in outpatients. Am J Health-Syst Pharm Ibid 1997;54:680-3.
17. Stimmell GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Am J Hosp Pharm 1982;39:1483-6.
18. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983;21:435-44.
19. Dong BJ. Pharmacist involvement in a thyroid clinic. Am J Hosp Pharm 1990;47:356-61.
20. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulant clinic with usual medical care. Arch Intern Med 1998;158:1641-7.
21. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol 1995;48:545-7.
22. Magregor SH, Hamley JG, Dunbar JA, Dodd TRP, Cromarty JA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ 1996;312:560.
23. Hebron B, Jay C. Pharmaceutical care for patients undergoing elective ENT surgery. Pharm J 1998;260:65-6.
24. Jay C. The role of the pre-admissions pharmacist. Hosp Pharm 1998;5:105-6.
25. Culshaw M, Dawes S. Assessing the value of a discharge pharmacist. Pharm Manage 1998;14(2):22-3.
26. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
27. Child D, Hirsch C, Berry M. Health care professionals' views on hospital pharmacist prescribing in the United Kingdom. Int J Pharm Pract 1998:6:159-69.
28. Stimmel GL. Political and legal aspects of pharmacist prescribing. Am J Hosp Pharm 1983;40:1343-4.
29. Setting the records straight: A study of hospital medical records. London: HM Stationery Office, 1995.
30. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.
31. Pharmacy: The report of a committee of inquiry appointed by the Nuffield Foundation. London: Nuffield Foundation, 1986.
32. Medicines, ethics and practice. A guide for pharmacists. Number 22. London: Royal Pharmaceutical Society of Great Britain, July 1999: 92-3.
33. Luker K, Austin L, Hogg C, Ferguson B, Smith K. Nurse prescribing: The views of nurses and other health care professionals. Br J Comm Health Nursing 1997;2(2):69-74.
34. Dodds LJ. An objective assessment of the role of the pharmacist in medication and compliance history taking. Br J Pharm Pract 1982;4:12-24.
35. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. Am J Hosp Pharm 1983;40:1541-2.
36. Finch J. Professional liability: what the law actually is. Br J Anaesth 1994;73:3-9.
37. Appelbe GE, Wingfield J. Dale and Appelbe's Pharmacy Law and Ethics. 6th ed. London: The Pharmaceutical Press, 1997.
38. Galt KA. The key to pharmacist prescribing: collaboration. Am J Health-Syst Pharm 1995;52:1696-9.
39. Farrell J, North-Lewis P, Cross M. Pharmacist prescribing in the United States. Pharm J 1997;259:187-90.
40. Cross MA. Hospital pharmacist prescribing in the new age. Pharm J Ibid 1996;257:286-8.
41. Whittenburg SJ. Obtaining prescribing authority for pharmacists: lessons learned. Am J Health-Syst Pharm 1995;52:1616-24.
42. Webb CE. Prescribing medications: changing the paradigm for a changing health care system. Am J Health-Syst Pharm Ibid 1995;52:1693-5.
43. Desikan R, Holiday-Goodman M, Siganga R W, Lively B T. Prescribing authority: an examination of Ohio pharmacists' opinions. Am Pharm 1995;NS35:19-23.
44. Shefcheck SL, Thomas J. The outlook for pharmacist initiation and modification of drug therapy. J Am Pharm Assoc 1996;NS36(12):597-604.